Kala Pharmaceuticals Inc (KALA) financials · $54.3M cap
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Kala Pharmaceuticals Inc (KALA) $54.3M cap.
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | N/A | N/A |
| Operating Income | -$39.2M | -$41.0M |
| Net Income | -$27.0M | -$38.5M |
| EPS (Diluted) | -$3.31 | -$10.15 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $9.49M | $55.5M |
| Current Assets | $9.49M | $52.8M |
| Cash & Equivalents | $7.56M | $51.2M |
| PP&E | $869.0K | $749.0K |
| Total Liabilities | $2.49M | $43.2M |
| Current Liabilities | $2.49M | $17.0M |
| Short-term Debt | N/A | $10.3M |
| Long-term Debt | N/A | $20.1M |
| Total Debt | N/A | $30.4M† |
| Shareholders' Equity | $7.00M | $12.3M |
| Retained Earnings | -$694.9M | -$667.9M |
† Total Debt: Derived: short-term debt plus long-term debt (no total debt stored).
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | -$32.0M | -$29.4M |
| Investing Cash Flow | -$15.0K | -$208.0K |
| Financing Cash Flow | -$11.6M | $29.9M |
| Net Change in Cash | -$43.6M | $286.0K |
FAQ
What is KALA P/E and revenue?
Kala Pharmaceuticals Inc (KALA) $54.3M cap.
What is KALA revenue?
KALA income-statement cache has no revenue figure yet.
Is KALA profitable?
Kala Pharmaceuticals Inc last cached net income is -$27.0M (FY2025).
What are KALA total assets?
Kala Pharmaceuticals Inc last cached total assets are $9.49M (FY2025).
What is KALA free cash flow?
No cached cash-flow row for KALA yet.
Not investment advice. Cached statements, not a live tape.